Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Avexitide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
    Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results

    08 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240808415481/en

    BUSINESSWIRE
    08 Aug 2024
    Share Share
    Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
    Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal

    24 Jul 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/amylyx-rebuilds-momentum-following-relyvrio-market-withdrawal

    BIOSPACE
    24 Jul 2024
    Share Share
    Amylyx Acquires Phase 3 GLP-1 Antagonist With FDA Breakthrough Status
    Amylyx Acquires Phase 3 GLP-1 Antagonist With FDA Breakthrough Status

    10 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240710172870/en

    BUSINESSWIRE
    10 Jul 2024
    Share Share
    Amylyx To Host Call On Avexitide Acquisition
    Amylyx To Host Call On Avexitide Acquisition

    09 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240709000861/en

    BUSINESSWIRE
    09 Jul 2024
    Share Share
    Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
    Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar

    22 Jun 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/amylyx-buy-bankrupt-eigers-experimental-drug-treat-low-blood-sugar-2024-06-21/

    REUTERS
    22 Jun 2024
    Share Share
    Eiger BioPharma Announces New Data Supporting Broader Potential of Avexitide
    Eiger BioPharma Announces New Data Supporting Broader Potential of Avexitide

    13 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-new-data-supporting-broader-potential-of-avexitide-in-patients-with-post-bariatric-hypoglycemia-and-hyperinsulinemic-hypoglycemia-after-gastrointestinal-surgeries-301566413.html

    PRNEWSWIRE
    13 Jun 2022
    Share Share